pharmacological interaction with quinoid antitumor drugs

References

• Goldin A. Dosing and sequencing for antineoplastic synergism in combination chemotherapy. Cancer 1984; 76: 1155–1159
   Google Scholar
• Steel G. G. The search for therapeutic gain in the combination of radiotherapy and chemotherapy. Radiother. Oncol. 1988; 11: 31–53
   PubMed Web of Science ®Google Scholar
• Di Marco A., Dasdia T., Pastori W. Interaction of calcium ions and CAMP on the cytotoxic effect of doxorubicin. Tumori 1984; 30: 217–221
   Google Scholar
• Cohen M. H. Enhancement of the antilunior ellrct of 1,3-bis(2-chlorocthyl)-l-nitrosourea by various psychotropic drugs in combination with calreine. J. Pharmacol. Exp Ther. 1975; 194: 475–479
   PubMedGoogle Scholar
• Orstavik J. Caffeine rensitive recovery of milomycin C treated mouse P-388 cells. Acta Pathol. Microbiol. Scand. 1972; 80: 900–904
   Google Scholar
• Miyamoto K., Matsunaga T., Waki Y, Koshiura R. Enhancement of mitomycin C uptake by isoproterenol in rat ascites hepatoma. J Pharmacobiodyn 1986; 9: 453–459
   Google Scholar
• Shinozaua S., Gomita Y, Araki Y. Protection against adriamycin (doxorubicin)-induced toxicity in mice by several clinically used drugs. Acta Med. Okayama, 41: 11
   Google Scholar
• Rogan A. M., Hamilton T. C., Young R. C., Kelecker R. W., Ozols R. F. Reversal of adriamycin resistance by verapamil in human ovarian cancer. Science 1984; 224: 994–995
   PubMed Web of Science ®Google Scholar
• Tsuruo T. Reversal of acquired resistancc to vinca alkaloids and anthracycline antibiotics. Cancer Treat. Rep 1983; 67: 889–894
   PubMedGoogle Scholar
• Tsuruo T., Lida H., Naganuma K., Tsukagoshi S., Sakurai Y. Promotion by verapamil of vincristine responsiveness in tumuur cell lines inherently resistant to the drug. Cancer Res. 1983; 43: 808–813
   PubMed Web of Science ®Google Scholar
• Lönn U., Lönn S. W-7, a calmodulin inhibitor. potentiates dacarbazine cytotoxicity in human neoplastic cells. Int. J. Cancer 1987; 39: 638–642
   Google Scholar
• Smith P. J., Mitheva J. J., Bleehen N. M. Potentlation of sensitivity to bleomycin and the drug-induced DNA damage in EMT6 cells by the calmodulin inhibitor trifluorperazine. Acta Physiol. Pharmacol. Bulg. 1987; 13: 41–45
   PubMedGoogle Scholar
• Biaglow J. E., Varnes M. E., Jacobson B., Suit H. D. Effect of calcium channel blocking drugs on tumor cell oxygen utilization. Adv. Exper. Med. Biol. 1986; 200: 583–589
   Google Scholar
• Herman E. H., Ferrans V. J. Prctrcatrnent with ICRF-187 provides long-lasting protection against chronic daumorubicin cardiotoxicity in rabbits. Ca. Chemother. Pharmtrcol. 1986; 16: 102–106
   PubMed Web of Science ®Google Scholar
• Herman E. H., Ferrans V. J., Myers C. E., van Vleet J. F. Comparison of the effectiveness of (±)-1, 2-bis(3,5-dioxopiperazinyl-I -yl)propane (ICRF-187) and N-acetylcysteine in preventing chronic doxorubicin cardiotoxicity in beagles. Cancer Res. 1986; 45: 276–281
   Google Scholar
• Dimitrov N. V., Hay M. B., Siew S., Hudler D. A., Charamella L. J., Ullrey D. E. Abrogation of adriamycin-induced cardiotoxicity by selenium in rabbits. Am. J. Pathol. 1987; 126: 376–383
   Google Scholar
• Zidenberg-Cherr S., Keen C. L. Influence of dietary manganese and vitamin E on adriamycin toxicity in mice. Toxicol. Lett. 1986; 30: 79–87
   Google Scholar
• Milei J., Boveris A., Ilesey S., Molina H. A., Storino R., Ortega D., Milei S. E. Amelioration of adriamycin-induced cardiotoxicity in rabbits by prenylamine and vitamins A and E. Am. Heart. J. 1986; 111: 95–102
   PubMedGoogle Scholar
• Olive P. L. DNA precipitation assay: A rapid and simple method for detecting DNA damage in mammalian cells. Environ. Mol. Mutag. 1988; 11: 487–495
   PubMed Web of Science ®Google Scholar
• Rydberg B. Detection of induced DNA strand breaks with improved sensitivity in human cells. Rad. Res. 1980; 81: 492–495
   PubMed Web of Science ®Google Scholar
• Sandström B. E.R., Johansson K. J. A direct assay for detection of chemically induced changes in the rejoining kinetics of radiation induced DNA strand breaks. J. Biochem. Biophys. Methods 1987; 14: 183–190
   PubMedGoogle Scholar
• Gralla R. J. Metoclopramide. A review of antiemetic trails. Drugs 1983, Suppl. I: 63–73
   Google Scholar
• Catino J. J., Francher D. M., Schuring J. E. Evaluation of cisdiamminedichloroplatinum(II) combined with metoclopramide or sodium thiosulphate on L1210 leukemia in vitro and in vivo. Cancer Chemother. Pharmacol. 1986; 18: 1–4
   PubMedGoogle Scholar
• Osborne R. J., Slevin M. L., Hunter R. W., Hamer J. Cardiac arrythmias during cytotoxic chemotherapy: Role of domperidone. Human Toxicol. 1985; 4: 617–623
   PubMedGoogle Scholar
• Osieka R., Glatte P., Pannenbäcker R., Schmidt C. G. Enhancement of semustine-induced cytotoxicity by chlorpromazine and caffeine in a human melanoma xenograft. Cancer Treatm. Pep. 1986; 70: 1167–1171
   PubMedGoogle Scholar
• Nierenberg D. W., Mamelok R. D. Toxic reaction to methotrexate in a patient receiving penicillin and furosemide. A possible interaction. Arch. Dermatol. 1983; 119: 449–450
   Google Scholar
• Nierenberg D. W. Competitive inhibition of methotrexate accumulation in rabbit kidney slices by nonsteroidal antiinflammatory drugs. J. Pharmacol. Exp. Ther. 1983; 226: 1–6
   PubMed Web of Science ®Google Scholar
• Williams W. M., Chen T. S., Huang K. C. Effects of penicillin on the renal tubular secretion of methotrexate in the monkey. Cancer Res. 1984; 45: 1913–1917
   Google Scholar
• Iven H., Brasch H. Influence of the antibiotics piperacillin. doxycycline, and tobramycin on the pharmacokinetics of methotrexate in rabbits. Cancer Chemother. Pharmacol. 1986; 17: 218–222
   PubMed Web of Science ®Google Scholar
• Zager R., Frisby S., Oliverio V. The effect of antibiotics and cancer chemotherapeutic agents in the cellular transport and the antitumor activity of methotrexate in L1210 murine leukemia. Cancer Res. 1973; 33: 1670–1676
   Google Scholar
• Spector G. N., Wang Y. M., Gleiser C. A., Chan R. C., Van Eys J. Effects of gentamicin and irradiation of the toxicity of high-dose methotrexate in rats. Cancer Treatm. Rep. 1980; 64: 989–991
   Google Scholar
• Gonzales-Vitale J. C., Hayes D. M., Cvitkovic E., Sternberg S. S. Acute renal failure after cisdichlorodiamineplatinum(II) and gentamicin-cephalothin therapies. Cancer Trearm. Rep. 1978; 62: 693–698
   Google Scholar
• Bellotti M. G., Bossa R. G.I. Interazione tra cefotaxima eadriamicina. G. Ital. Chemioter. 1984; 31: 73
   Google Scholar
• Valeriote F., Medoff G., Dieckman J. Potentiation of anticancer agent cytotoxicity against sensitive and resistant AKR leukemia by amphotericin BI. Cancer Res. 1979; 39: 2041–2045
   PubMed Web of Science ®Google Scholar
• Presant C., Klahr C., Santala R. Amphotericin B induction of sensitivity to adriamycin, 1,3-bis (2-chloroethyl)-nitrosourea (BCNU) plus cyclophosphamide in human neoplasia. Ann. Intern. Med. 1977; 86: 47–51
   PubMed Web of Science ®Google Scholar
• Henry N., Bolard J. Synergistic incorporation of daunorubicin in erythrocytes in the presence of polyene antibiotics. Role of the membrane potential. Biochim. Biophys. Acta 1986; 16: 84–92
   Google Scholar
• Pera M. F., Zook B. C., Harder H. C. Effects of furosemide diuresis on the nephrotoxicity and physiological dispostion of cis dichlorodiaminoplantinum(II) in rats. Cancer Res. 1979; 39: 1269–1278
   PubMedGoogle Scholar